Back to top

Novo Nordisk Tests New Obesity Dose Strategy, Keeping Its Pipeline Momentum

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study titled “Evaluation of Different Dose Escalation Regimens for NNC...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novo Nordisk A/S (NVO)